Third phase trials of the Oxford University Vaccine Project will also be performed in India. More than 1500 Indian people in hospitals in different parts of the world will be screened for this vaccine. The trial can start from the first week of August. The name of this vaccine project is AZD1222.
In Brazil, the first step of the vaccine recorded promising results from human trials. Bulk development of this vaccine will also begin in September. In a study published in The Tribune newspaper, the CEO of the Serum Institute said a few days ago that the Oxford vaccine may have arrived by the end of this year.
According to a study published in the journal, scientists have found that the experimental Kovid-19 vaccine has developed a double immune system in people between 18 and 55 years of age. Most of the vaccines that have been developed so far create antibodies. At the same time, Oxford vaccine also produces a white blood cell (Killer T-cell) with antibodies.